Associations between testosterone levels in men at age 31 and quality of life, self-reported health, and morbidity at age 46: the Northern Finland birth cohort 1966
Endocrine Connections · 01.11.2026 · 15 (11)
DOI: 10.1530/ec-26-0523 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, online erschienen am 26.10.2026. Verfasst von A Tuomisto und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu, Finland. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
We investigated self-reported health status, comorbidity, and quality of life (QoL) in men at age 46 across testosterone (T) quartiles at age 31 and evaluated whether differences existed between these quartiles. Design and methods The study population was a population-based cohort comprising men born in Northern Finland in 1966. T concentrations were measured at age 31 (n = 2,691) and categorized into quartiles: Q1 < 17.2 nmol/L (n = 660), Q2 = 17.2–20.99 nmol/L (n = 681), Q3 = 21.0–25.49 nmol/L (n = 664), and Q4 ≥ 25.5 nmol/L (n = 686). The 15D questionnaire and other health and medical condition surveys were administered at age 46.
Results
Men in Q1 were more obese, less likely to smoke, and consumed less alcohol compared with men in Q4 (P < 0.001 for all). Most men reported average, good, or excellent health, and no significant differences were observed between the T quartiles. Men in Q1 also had a lower prevalence of substance use disorders (P = 0.01), were less depressed (P = 0.03), and were less sexually active (P = 0.03), but exhibited a higher prevalence of metabolic (P < 0.001) and gastrointestinal diseases (P = 0.004) than men in Q4. After adjusting for waist circumference, there were no significant differences in sexual activity, metabolic, or gastrointestinal diseases. Overall QoL was excellent across study groups and was slightly better in Q1 than in Q4 in adjusted models (P = 0.02).
Conclusion
The overall QoL was excellent across all T quartiles. In this study population, T levels in adulthood seem not to be associated with notable differences in self-reported health, comorbidity, or quality of life in middle age, especially when adjusted for WC. Significance Statement This topic is clinically significant because studies have shown that T levels have declined over the past several decades, even among healthy men. Clinicians should, therefore, be aware of the potential impact of low testosterone on men’s mental health, sexual function, and overall quality of life.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Oulu University Hospital, Wellbeing Services County of North Ostrobothnia , Oulu, Finland.
- Medical Research Center, Research Unit of Clinical Medicine, University of Oulu , Oulu, Finland.
ORCID-Profile: A Tuomisto
Zitieren
APA
Tuomisto, A., Pinola, P., Pesonen, P., Morin-Papunen, L., & Niinimäki, M. (2026). Associations between testosterone levels in men at age 31 and quality of life, self-reported health, and morbidity at age 46: the Northern Finland birth cohort 1966. Endocrine Connections, 15(11). https://doi.org/10.1530/ec-26-0523
Vancouver
Tuomisto A, Pinola P, Pesonen P, Morin-Papunen L, Niinimäki M. Associations between testosterone levels in men at age 31 and quality of life, self-reported health, and morbidity at age 46: the Northern Finland birth cohort 1966. Endocrine Connections. 2026;15(11). doi:10.1530/ec-26-0523
BibTeX
@article{Tuomisto2026,
author = {Tuomisto, A and Pinola, P and Pesonen, P and Morin-Papunen, L and Niinimäki, M},
title = {Associations between testosterone levels in men at age 31 and quality of life, self-reported health, and morbidity at age 46: the Northern Finland birth cohort 1966},
journal = {Endocrine Connections},
year = {2026},
volume = {15},
number = {11},
doi = {10.1530/ec-26-0523}
}
EUVIMED